Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Quality of Life in Emicizumab-Treated People with Hemophilia A in the ATHN 7 Hemophilia Natural History Study - an Assessment of Baseline PROMIS®-29 Scores

Tyler W. Buckner, Nabil Daoud, Lucy Lee, Elise Lim, Jonathan Schwartz, Karina Raimundo, Michael Recht

Blood (2023) 142 (Supplement 1): 3998.

https://doi.org/10.1182/blood-2023-174092

Published: 2023

Journal Articles

Emicizumab and Females with Hemophilia A: Case Series from ATHN 7

Michael Recht, Nabil Daoud, Lucy Lee, Paul Morton, Leslie J. Raffini

Blood (2022) 140 (Supplement 1): 2745–2746.

https://doi.org/10.1182/blood-2022-157754

Published: 2022

Journal Articles

Hemophilia Natural History Study (ATHN 7): Safety of Current Therapies for People with Hemophilia A or B

Tyler W. Buckner, Shannon L Carpenter, Nabil Daoud, Nikki Hirsh, Thomas W. McLean, Carrie O'Neill, Leslie J. Raffini, Ayesha Zia, Michael Recht

Blood (2021) 138 (Supplement 1): 2105.

https://doi.org/10.1182/blood-2021-146726

Published: 2021

Journal Articles

Hemophilia Natural History Study (ATHN 7): Baseline Characteristics, Adverse Events, and Self-Reported Health Status of Individuals with Hemophilia a and B

Tyler W. Buckner, MDMSc, Shannon L Carpenter, MD, Stacy E. Croteau, MD, Adam Cuker, MDMS, Nabil Daoud, MA, Christine L Kempton, MDMSc, Lynn M Malec, MD, Thomas W. McLean, MD, Leslie J. Raffini, MD, Janice M Staber, MD, Michael Wang, MD, Crystal Watson, BS, Ayesha Zia, MD, Michael Recht, MD PhD

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-137696

Published: 2020